In the Matter of GlaxoSmithKline, PLC (Augmentin)

States alleged that GlaxoSmithKline fraudulently obtained patent protection for Augmentin and then delayed generic entry through sham patent litigation. Through this conduct, GlaxoSmithKline unlawfully maintained its monopoly over Augmentin. A $3.5 million multistate settlement for state proprietary claims was entered into by the participating states and GlaxoSmithKline.

Read More →

In Re Relafen Antitrust Litigation

States sued manufacturer of antidepressant Relafen, alleging patent misuse and sham litigation designed to prevent generic entry. Parties settled the state proprietary claims for $10 million.

Read More →

Texas v. Zurich American Insurance Company (In re Insurance Brokerage Antitrust Lit. (D.C. No. 04-cv-05184, D.N.J.)

Zurich settled claims involving payment of contingent commissions and submission of false bids for insurance coverage.

Read More →

Maryland v. SmithKline Beecham Corp., No. 2:06-cv-01298-JP (E.D.Pa Mar. 27, 2006)

States sued manufacturer of antitdepressant Paxil, alleging patent misuse and sham litigation designed to prevent generic entry. Parties settled for $14 million.

Read More →

U.S. and Texas, et al v. Oracle, Corporation, No.C-04 0807 (JCS )(N.D.Cal.2005)

Merger review of two of the most dominant vendors of high function Human Resource Management software and high function Financial Management Services software.

Read More →

Curran v. Schwinn Bicycle Co. 92183022 /CE150758 (Cir. Ct. for Baltimore City 1992).

Resalw Price Maintenance; joint advertising and sale at set prices during a three day sales event.

Read More →

Curran v. Trek Bicycle Corp., No. 92183023/CE150759 (Cir. Ct. Baltimore City 1992).

Resale Price Maintenance: joint advertising and sale at set prices during a three day sales event.

Read More →

Connecticut v. Mylan Laboratories, Inc. (In re Lorazepam & Clorazepate Antitrust Litigation), MDL No. 1290 (D.D.C. June 15, 2000) 205 F.R.D. 369 (D.D.C. 2002); No. 98 CV 3115 (D.D.C. 2000) – complaint

Plaintiff States alleged that Mylan Laboratories, Inc.(Mylan) and other drug companies entered into illegal agreements to monopolize the market for certain generic anti-anxiety drugs.

Read More →

Curran v. Electrolux Corp., (Cir. Ct. for Baltimore City, 1991) (filed 12/19/91; approved 12/31/91)

Resale Price Maintenance of vacuum cleaners

Read More →

New York v. Microsoft Corp., 97 F. Supp. 2d 59 (D.D.C. 2000)

U.S. Department of Justice and the Plaintiff States alleged that the Defendant, Microsoft Corporation violated State and Federal law by maintaining a monopoly in the market for Intel-compatible personal computer operating systems and by illegally tying its Windows operating system to its Internet Explorer browser.

Read More →